{
    "meeting_annotations": [
        {
            "speaker": "Tania Lupoli",
            "timestamp": "00:00-00:25",
            "transcript": "you could use that to build off same as we did with DNA, build off of that information to predict folds and I mean I guess RNA folding is still its own problem. But yeah I just wanted to clarify that. But yeah I mean the field moved away from Edman sequencing so what's the is the advantage would be to do single molecule. That's the point that you guys were making that it would be",
            "speaking_duration": 25,
            "interuption": "No",
            "screenshare": "No",
            "screenshare_content": "None",
            "other": "None"
        },
        {
            "speaker": "Neil Kelleher",
            "timestamp": "00:25-00:40",
            "transcript": "Yeah because when you when you do Edman at single molecule you then don't have that phase problem where you could only get 30 or 40 amino acids in right because then it would go out of phase and that but single molecule you could in theory",
            "speaking_duration": 15,
            "interuption": "Yes",
            "screenshare": "No",
            "screenshare_content": "None",
            "other": "None"
        },
        {
            "speaker": "Tania Lupoli",
            "timestamp": "00:40-01:09",
            "transcript": "Yeah. I was thinking about something else you said with right the problem being PTMs, the problems that they present and I was wondering if you could first sort your samples you know by PTM like you know anti- anti-phos antibodies, anti-ubiquitin, whatever, um as a way to kind of at least simplif not simplify that problem but then you'd know what I guess the problem is you have mixed PTMs and you'd have multiple proteins in different",
            "speaking_duration": 29,
            "interuption": "No",
            "screenshare": "No",
            "screenshare_content": "None",
            "other": "None"
        },
        {
            "speaker": "Ross Wang",
            "timestamp": "01:09-01:21",
            "transcript": "I was I was just about to say there are also multiple PTM sites and a lot of times I think mass spec researchers had to deal with cross talk between PTMs and",
            "speaking_duration": 12,
            "interuption": "Yes",
            "screenshare": "No",
            "screenshare_content": "None",
            "other": "None"
        },
        {
            "speaker": "Tania Lupoli",
            "timestamp": "01:21-01:26",
            "transcript": "I guess if you found that protein in multiple bins though then you would say whatever",
            "speaking_duration": 5,
            "interuption": "No",
            "screenshare": "No",
            "screenshare_content": "None",
            "other": "None"
        },
        {
            "speaker": "Ross Wang",
            "timestamp": "01:26-01:39",
            "transcript": "Then it also goes to a temporal issues so because this is so dynamic and uh I see a lot of recent data on the post trace experiment so the the whole modulations can be a equilibrium and",
            "speaking_duration": 13,
            "interuption": "Yes",
            "screenshare": "No",
            "screenshare_content": "None",
            "other": "None"
        },
        {
            "speaker": "Tania Lupoli",
            "timestamp": "01:39-02:03",
            "transcript": "But isn't that isn't that the point that every time you do an experiment you're capturing it at a particular time. Yeah I guess it would need to be an imaging technique if it were to be more yeah like for you to actually measure changes over time if you didn't want it to be discontinuous.",
            "speaking_duration": 24,
            "interuption": "No",
            "screenshare": "No",
            "screenshare_content": "None",
            "other": "None"
        },
        {
            "speaker": "Stephen Yi",
            "timestamp": "02:03-02:37",
            "transcript": "Yeah I think it's a very important very good point. As long as you can somehow freeze the proteins they don't really do activities anymore going for further changes anything like that. I think yeah that's exactly what we are looking for so that you can really have one time point this is static you know hopefully frozen state we can study that and then time point two and onwards.",
            "speaking_duration": 34,
            "interuption": "No",
            "screenshare": "No",
            "screenshare_content": "None",
            "other": "This speaker's video is off; only a profile picture is visible."
        },
        {
            "speaker": "Neil Kelleher",
            "timestamp": "02:38-04:03",
            "transcript": "Yeah it's it's a tough thing to try to regularize the proteome because it has many so many different dimensions to it um and you can argue that of and then people end up wanting more than the analog of what the genome project did. You know notice what the genome project did it said no we don't want spatial information to start. No we don't want a thousand cancer genomes until we get the technology right. No we don't want genetic variation in the population. We we want 27 people we want a reference atlas and um the field of proteomics doesn't necessarily advertise its limitations first or seek to get composition of matter and and set a firm foundation. It's uh um",
            "speaking_duration": 85,
            "interuption": "No",
            "screenshare": "No",
            "screenshare_content": "None",
            "other": "None"
        },
        {
            "speaker": "Paul Selvin",
            "timestamp": "04:03-04:33",
            "transcript": "Also one well we used to have I guess five minutes before we should do the 15 minute makeup of the report. Is there at the level of you know an individual person or a couple of you guys you know have we thought of any possible projects I mean that it's not exactly the purpose of this particular session but",
            "speaking_duration": 30,
            "interuption": "Yes",
            "screenshare": "No",
            "screenshare_content": "None",
            "other": "None"
        },
        {
            "speaker": "Neil Kelleher",
            "timestamp": "04:33-05:52",
            "transcript": "we were we were talking about a five billion dollar project which is not not going to occur between two people or three people. Is there anything smaller that is you know the high risk high reward kind of payoff.",
            "speaking_duration": 79,
            "interuption": "No",
            "screenshare": "No",
            "screenshare_content": "None",
            "other": "None"
        },
        {
            "speaker": "Neil Kelleher",
            "timestamp": "05:52-05:54",
            "transcript": "Sorry sorry my bad.",
            "speaking_duration": 2,
            "interuption": "Yes",
            "screenshare": "No",
            "screenshare_content": "None",
            "other": "None"
        },
        {
            "speaker": "Neil Kelleher",
            "timestamp": "05:57-05:59",
            "transcript": "That's one answer.",
            "speaking_duration": 2,
            "interuption": "No",
            "screenshare": "No",
            "screenshare_content": "None",
            "other": "None"
        },
        {
            "speaker": "Tania Lupoli",
            "timestamp": "06:05-06:19",
            "transcript": "Alexis brought up reverse translation which I just saw someone wrote a proposal on in 2018 but it never happened so I feel like it's still fair game. What a great what a great proposal that would be I think.",
            "speaking_duration": 14,
            "interuption": "No",
            "screenshare": "No",
            "screenshare_content": "None",
            "other": "None"
        },
        {
            "speaker": "Ross Wang",
            "timestamp": "06:19-06:26",
            "transcript": "Yeah I was about to say whoever figured out how to amplify proteins is a big shot in there.",
            "speaking_duration": 7,
            "interuption": "No",
            "screenshare": "No",
            "screenshare_content": "None",
            "other": "None"
        },
        {
            "speaker": "Lars Plate",
            "timestamp": "06:26-06:56",
            "transcript": "I like this idea Alexis that you brought up about the tRNA synthetases right because they're sort of the molecular machines that really have high specificity for particular amino acids and they they link it up to a to a tRNA which is then a nucleic acid code but if you if you can find a way to basically",
            "speaking_duration": 30,
            "interuption": "No",
            "screenshare": "No",
            "screenshare_content": "None",
            "other": "None"
        },
        {
            "speaker": "Alexis C Komor",
            "timestamp": "06:56-06:58",
            "transcript": "Will that even work?",
            "speaking_duration": 2,
            "interuption": "Yes",
            "screenshare": "No",
            "screenshare_content": "None",
            "other": "None"
        },
        {
            "speaker": "Lars Plate",
            "timestamp": "06:58-07:13",
            "transcript": "somehow yeah if you can evolve or engineer it in some ways to then yeah even just the recognition aspect might be might be a small project and then I don't know then it would still have to be linked up in some ways to some some readout.",
            "speaking_duration": 15,
            "interuption": "No",
            "screenshare": "No",
            "screenshare_content": "None",
            "other": "None"
        },
        {
            "speaker": "Alexis C Komor",
            "timestamp": "07:13-07:33",
            "transcript": "Yeah it's almost just like can we come up with like a code for protein recognition like how there is with nucleic acids because like you know you can say oh just make an antibody for your you know favorite protein but that takes so much longer than just like designing a complementary nucleic acid probe.",
            "speaking_duration": 20,
            "interuption": "No",
            "screenshare": "No",
            "screenshare_content": "None",
            "other": "None"
        },
        {
            "speaker": "Ross Wang",
            "timestamp": "07:33-07:44",
            "transcript": "Yeah you need something like Watson-Crick base pairing that happening in nucleic acid that can collect the template of protein to your product.",
            "speaking_duration": 11,
            "interuption": "No",
            "screenshare": "No",
            "screenshare_content": "None",
            "other": "None"
        },
        {
            "speaker": "Tania Lupoli",
            "timestamp": "07:44-08:11",
            "transcript": "Yeah. I mean the synthetases do it through like a sieve mechanism where they check if the side chain is too big or too small so it could be something so basic because you already know you're at a you know you purify the proteins away from everything else so that you're only dealing with side chains at this point.",
            "speaking_duration": 27,
            "interuption": "No",
            "screenshare": "No",
            "screenshare_content": "None",
            "other": "None"
        },
        {
            "speaker": "Alexis C Komor",
            "timestamp": "08:11-08:11",
            "transcript": "denature the proteins.",
            "speaking_duration": 0,
            "interuption": "Yes",
            "screenshare": "No",
            "screenshare_content": "None",
            "other": "None"
        },
        {
            "speaker": "Tania Lupoli",
            "timestamp": "08:11-08:33",
            "transcript": "Right you just need to know maybe the size of the of the side chain. If the sides could be you know if they're different enough which you know they are because they're distinguished that way.",
            "speaking_duration": 22,
            "interuption": "No",
            "screenshare": "No",
            "screenshare_content": "None",
            "other": "None"
        },
        {
            "speaker": "Paul Selvin",
            "timestamp": "08:33-09:07",
            "transcript": "Right. Should we it's now 2 o'clock and by 2:15 we should have some sort of summary. So Laura I believe you are going to present this on Lars is supposedly made a long list. We should try to get together and make it coherent.",
            "speaking_duration": 34,
            "interuption": "No",
            "screenshare": "No",
            "screenshare_content": "None",
            "other": "None"
        },
        {
            "speaker": "Laura Sanchez",
            "timestamp": "09:07-09:35",
            "transcript": "Sure. Yeah does everyone have the I'm going to copy some of it into the slide. Uh but I think I like the way Lars already laid it out with challenges and solutions so I think I might just take that in as it is because I think there was like an overarching like what are the problems with mass spectrometry what do they butt up and that kind of drove the rest of the discussion.",
            "speaking_duration": 28,
            "interuption": "No",
            "screenshare": "No",
            "screenshare_content": "None",
            "other": "None"
        },
        {
            "speaker": "Lars Plate",
            "timestamp": "09:36-09:53",
            "transcript": "And I had some like we started discussing some limitations of current um approaches so that's kind of what I led up with. Um there were some good points there as well. I can share the link again to the the notes.",
            "speaking_duration": 17,
            "interuption": "No",
            "screenshare": "No",
            "screenshare_content": "None",
            "other": "None"
        },
        {
            "speaker": "Paul Selvin",
            "timestamp": "09:59-10:07",
            "transcript": "This is in group three. Laura you are going to present this and Lars has supposedly made a long list.",
            "speaking_duration": 8,
            "interuption": "No",
            "screenshare": "No",
            "screenshare_content": "None",
            "other": "None"
        },
        {
            "speaker": "Laura Sanchez",
            "timestamp": "10:08-10:08",
            "transcript": "Sure.",
            "speaking_duration": 0,
            "interuption": "No",
            "screenshare": "No",
            "screenshare_content": "None",
            "other": "None"
        }
    ]
}